For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 170,640 | |||
| Selling, general and administrative | 65,382 | |||
| Total operating expenses | 236,022 | |||
| Loss from operations | -236,022 | |||
| Interest income | 27,761 | |||
| Interest expense | 3,607 | |||
| Other income (expense) | 45 | |||
| Total other income (expense), net | 24,199 | |||
| Loss before income taxes | -211,823 | |||
| Income tax expense | 361 | |||
| Net loss | -212,184 | |||
| Basic EPS | -6.01 | |||
| Diluted EPS | -6.01 | |||
| Basic Average Shares | 35,295,663 | |||
| Diluted Average Shares | 35,295,663 | |||
Disc Medicine, Inc. (IRON)
Disc Medicine, Inc. (IRON)